1
|
Roesel C, Kambartel K, Kopeika U, Berzins A, Voshaar T, Krbek T. Lazarus-type tumour response to therapy with nivolumab for sarcomatoid carcinomas of the lung. ACTA ACUST UNITED AC 2019; 26:e270-e273. [PMID: 31043837 DOI: 10.3747/co.26.4377] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Pulmonary sarcomatoid carcinoma (psc) is a rare subtype of non-small-cell lung carcinoma with a poor prognosis and poor response to chemotherapy and radiotherapy. A previous study reported that psc expresses high levels of PD-L1, suggesting the potential efficacy of immune checkpoint inhibitors in these tumours. We report 2 cases of patients with a lung sarcomatoid carcinoma. Both patients initially underwent curative lung resection, but developed early recurrent disease. Because PD-L1 was highly expressed in the tumour cells, we initiated therapy with nivolumab, which showed good efficacy, almost complete radiologic tumour remission, and a remarkable improvement in the condition of those patients. Immune checkpoint inhibitors targeting PD-1 might be a valuable therapy option for pscs.
Collapse
Affiliation(s)
- C Roesel
- Department for Thoracic Surgery, Lung Cancer Center, Bethanien Hospital, Moers, Germany
| | - K Kambartel
- Department of Pneumology and Allergy, Lung Cancer Center, Bethanien Hospital, Moers, Germany
| | - U Kopeika
- Department for Thoracic Surgery, Lung Cancer Center, Bethanien Hospital, Moers, Germany
| | - A Berzins
- Department for Thoracic Surgery, Lung Cancer Center, Bethanien Hospital, Moers, Germany
| | - T Voshaar
- Department of Pneumology and Allergy, Lung Cancer Center, Bethanien Hospital, Moers, Germany
| | - T Krbek
- Department for Thoracic Surgery, Lung Cancer Center, Bethanien Hospital, Moers, Germany
| |
Collapse
|
2
|
Kambartel K, Möhlenkamp S, Stark R, Freis H, Rösel C, Veelken D, Geier B, Krbek T, Voshaar T. Haemoptoe bei Aortenulkus – ein Tumor-assoziierter Notfall. Pneumologie 2018. [DOI: 10.1055/s-0037-1619150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- K Kambartel
- Pneumologie und Thorakale Onkologie, Lungenzentrum, Krankenhaus Bethanien Moers
| | - S Möhlenkamp
- Medizinische Klinik II, Kardiologie, Angiologie, Internistische Intensivmedizin, Krankenhaus Bethanien Moers
| | - R Stark
- Medizinische Klinik III, Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin, Krankenhaus Bethanien Moers
| | - H Freis
- Gefäßchirurgie, Krankenhaus Bethanien Moers
| | - C Rösel
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | - D Veelken
- Radiologie und Nuklearmedizin, Krankenhaus Bethanien Moers
| | - B Geier
- Gefäßchirurgie, Krankenhaus Bethanien Moers
| | - T Krbek
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | - T Voshaar
- Pneumologie, Krankenhaus Bethanien Moers
| |
Collapse
|
3
|
Kambartel K, Eggert J, Liebisch P, Klages H, Yildirim A, Mlynek-Kersjes ML, Kopeika U, Lücker F, Rösel C, Schweretfeger T, Krbek T, Voshaar T. Wann ist ein Patien alt? Einfluss auf die Behandlungsergebnisse des Lungenkarzinoms im Stadium IV. Pneumologie 2017. [DOI: 10.1055/s-0037-1598458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- K Kambartel
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| | | | | | | | - A Yildirim
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| | | | - U Kopeika
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| | | | - C Rösel
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | | | - T Krbek
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | - T Voshaar
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| |
Collapse
|
4
|
Krbek T, Kopeika U, Rösel C, Kambartel K, Voshaar T. Thoraxchirurgie im Alter. Pneumologie 2017. [DOI: 10.1055/s-0037-1598265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- T Krbek
- Lungenzentrum, Krankenhaus Bethanien Moers
| | - U Kopeika
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | - C Rösel
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | | | - T Voshaar
- Med. Klinik III, Pneumologie, Krankenhaus Bethanien Moers
| |
Collapse
|
5
|
Kambartel K, Eggert J, Kopeika U, Liebisch P, Mlynek-Kersjes ML, Rösel C, Scheffler M, Yildirim A, Krbek T, Wolf J, Büttner R, Voshaar T. Erfolgreiche Therapie mit Afatinib und Crizotinib bei einer cMET-Amplifikation als Ursache einer sekundären EGFR-Resistenz. Pneumologie 2017. [DOI: 10.1055/s-0037-1598336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- K Kambartel
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| | | | - U Kopeika
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| | | | | | - C Rösel
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | - M Scheffler
- Klinik I für Innere Medizin I, Centrum für Integrierte Onkologie (Cio), Universitätsklinikum Köln
| | - A Yildirim
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| | - T Krbek
- Thoraxchirurgie, Krankenhaus Bethanien Moers
| | - J Wolf
- Klinik I für Innere Medizin I, Centrum für Integrierte Onkologie (Cio), Universitätsklinikum Köln
| | - R Büttner
- Zentrum für Pathologie, Universitätsklinik Köln
| | - T Voshaar
- Lungenzentrum, Pneumologie, Krankenhaus Bethanien Moers
| |
Collapse
|
6
|
Kambartel K, Yildirim A, Mlynek-Kersjes ML, Krbek T, Kopeika U, Eggert J, Liebisch P, Voshaar T. Bedeutung einer schweren COPD bei der palliativen Chemotherapie des Lungenkarzinoms. Pneumologie 2016. [DOI: 10.1055/s-0036-1571969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
7
|
Kambartel K, Krbek T, Mlynek-Kersjes ML, Kopeika U, Yildirim A, Klages H, Lücker F, Eggert J, Liebisch P, Voshaar T. Vergleich von primärer und neoadjuvanter Operation beim Lungenkarzinom im Stadium IIIA-N2. Pneumologie 2016. [DOI: 10.1055/s-0036-1572146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Kopeika U, Traykov P, Aivars B, Kambartel KO, Voshaar T, Krbek T. 30- und 90-tägige Mortalität nach einer anatomischen Lungenresektion. Zentralbl Chir 2015. [DOI: 10.1055/s-0035-1559938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Kambartel K, Griesinger F, Krbek T, Voshaar T, Willborn K. Die Behandlung in einem Lungenkrebszentrum ist mit einem längeren Überleben assoziiert. Pneumologie 2015. [DOI: 10.1055/s-0035-1544652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
10
|
Kambartel K, Eggert J, Kopeika U, Liebisch P, Stais P, Krbek T, Voshaar T. Nutzen einer adjuvanten Chemotherapie bei unselektionierten Patienten. Pneumologie 2015. [DOI: 10.1055/s-0035-1544779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
11
|
Kambartel K, Filipiak A, Krbek T, Montag M, Voshaar T. Darstellung einer aberierenden Bronchialarterie mittels endobronchialem Ultraschall (EBUS). Pneumologie 2014. [DOI: 10.1055/s-0034-1367811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
Kambartel K, Voshaar T, Krbek T, Jotzo P. Welche Wünsche haben Patienten an das Aufklärungsgespräch über die Diagnose Lungenkrebs. Ergebnisse einer Patientenbefragung. Pneumologie 2014. [DOI: 10.1055/s-0034-1367957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
13
|
Kambartel K, Filipiak A, Hüschen H, Krbek T, Voshaar T. [Foreign body removal with Roth-Net®]. Pneumologie 2013; 67:520-1. [PMID: 24006199 DOI: 10.1055/s-0033-1344594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
There are different tools for the removal of endobronchial foreign bodies. The Roth-Net® is a further development of the Dormia basket. It enables an easy and sure retraction of a foreign body from the bronchial system. This will be presented in a case report.
Collapse
Affiliation(s)
- K Kambartel
- Medizinische Klinik III, Krankenhaus Bethanien, Moers.
| | | | | | | | | |
Collapse
|
14
|
Kambartel K, Hüschen H, Kopeika U, Krbek T, Voshaar T. Fortbildungsveranstaltungen von Lungenkrebszentren führen zu keiner vermehrten Patientenzuweisung. Pneumologie 2013. [DOI: 10.1055/s-0033-1334703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
15
|
Kambartel K, Stais P, Hüschen H, Kopeika U, Krbek T, Voshaar T. Lungenfunktionsveränderungen nach Lobektomie vs. anatomischer Segmentresektion beim Lungenkarzinom unter Berücksichtigung der Lungenüberblähung. Pneumologie 2013. [DOI: 10.1055/s-0033-1334680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
16
|
Abstract
Diagnostic findings of mediastinal metastasis are an important factor for the prognosis of and therapy for lung cancer. In this retrospective study we examined the role of endobronchial ultrasound with transbronchial needle aspiration (EBUS) and mediastinoscopy (MS) in patients with confirmed lung cancer. Between 01/2009 and 07/2011 we performed 111 EBUS procedures [partly in combination with transoesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)] and 88 mediastinoscopies. The diagnostic accuracy of EBUS (94%) was superior to that of MS (86%) (p < 0.05). The negative predictive value of EBUS and MS was 83% for both, the sensitivity was 94% vs. 58%, the prevalence of N2 /N3 was 84% vs. 32% and the rate of complications was 0% vs. 3%. Due to the at least similar accuracy the EBUS should be the first diagnostic procedure for histological staging of the mediastinum in patients with lung cancer.
Collapse
Affiliation(s)
- K Kambartel
- Lungenzentrum Bethanien Moers, Abteilung für Pneumologie, Allergologie, Zentrum für Schlaf- und Beatmungsmedizin.
| | | | | |
Collapse
|
17
|
Eberhardt W, Gauler T, Welter S, Krbek T, Stuschke M, Pöttgen C. Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen Lungenkarzinoms. Onkologe 2011. [DOI: 10.1007/s00761-011-2035-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
18
|
Theegarten D, Wohlschläger J, Krbek T, Tintelnot K, Anhenn O. Positiver pulmonaler PET-CT-Herd bei einem Bauingenieur. Pneumologie 2010. [DOI: 10.1055/s-0030-1251218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
19
|
Poettgen C, Eberhardt W, Gauler T, Krbek T, Berkovic K, Abu Jawad J, Welter S, Teschler H, Stamatis G, Stuschke M. Is PET/CT Response of Prognostic Value in Intensified Definitive Chemoradiation for Locally Advanced Non–small Cell Lung Cancer? Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
20
|
Theegarten D, Sönke K, Pöttgen C, Krbek T, Tötsch M, Eberhardt W. Bedeutung der Reparaturproteine hMLH2 und hMSH2 für das Ansprechen auf eine cis-Platin-basierte Chemotherapie bei Patienten mit fortgeschrittenem Nicht-kleinzelligem Lungenkarzinom (NSCLC). Pneumologie 2009. [DOI: 10.1055/s-0029-1213931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
21
|
Abstract
BACKGROUND Repeat cervical mediastinoscopy is a diagnostic surgical procedure for preoperative nodal staging in patients with insufficient first mediastinoscopy, with recurrent or second primary lung neoplasms, and following induction chemotherapy or chemo-/radiotherapy for locally advanced lung cancer. The aim of this study was to critically analyse indications, technical characteristics, intra- and postoperative complications, also to define selection criteria for patients with a higher probability of successful complete resection. MATERIAL AND METHODS 279 patients with lung cancer (66 female and 213 male patients, mean age 58 years, range 28 to 78 years) underwent repeat mediastinoscopy from 1968 to 2004, 12 because of inadequate first procedure (group A), 67 because of recurrent lung cancer (group B) 35 because of second primary lung cancer (group C), and 165 following induction chemo-/radiotherapy for IIIa and IIIb disease (group D). The interval between first and second procedure was 17 days (range, 12 - 38) in group A, 14 months (range, 5 - 29) in group B, 27 months (range, 19 - 124) in group C, and 132 days (range, 113 - 145) in group D. RESULTS No intra- or postoperative deaths were observed, 7 patients developed minor complications. N2 or N3 disease was found in 3/12 patients of group A (25 %), in 17/67 patients of group B (25.4 %) and in 6/35 patients of group C (17.1 %). Of the 116 patients with N2, and 49 with N3 disease before induction treatment (group D), repeat mediastinoscopy showed 126 N0, 20 N2 and 14 N3 status. Because of the presence of inseparable adhesions repeat mediastinoscopy was not possible in 5 cases. Five-year survival for patients with persistent N2 in repeat mediastinoscopy was despite surgery only 5 %. CONCLUSION Repeat mediastinoscopy is a safe explorative procedure for the restaging of patients with primary locally advanced, recurrent or second primary lung cancer. In patients after induction treatment it is, however, less sensitive than the primary mediastinoscopy because of adhesions and fibrotic tissue. Patients with persistent N2 or N3 disease in repeat mediastinoscopy have a poor survival so that the indication for surgery has to be taken into consideration very carefully.
Collapse
Affiliation(s)
- G Stamatis
- Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen-Heidhausen.
| | | | | | | | | |
Collapse
|
22
|
Korfee S, Pötttgen C, Cortés-Incio D, Müller M, Kaczmarczyk P, Theegarten D, Gauler L, Krbek T, Seeber S, Eberhardt W. P-067 Impact of mismatch repair protein expression on cisplatinum-basedchemotherapeutic response in patients with stage III non-small-cell lung cancer (NSCLC). Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80561-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
23
|
Gauler T, Sailer V, Pöttgen C, Korfee S, Krbek T, Stamatis G, Wilke H, Seeber S, Stuschke M, Eberhardt W. O-034 Preoperative chemotherapy and concurrent radio-chemotherapyfollowed by definitive surgery (“Trimodality”) in patients with locally advanced inoperable non-small-cell lung cancer stage IIIA/IIIB — 10-year-survival results. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80166-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Fujimoto T, Zaboura G, Fechner S, Hillejan L, Schröder T, Marra A, Krbek T, Hinterthaner M, Greschuchna D, Stamatis G. Completion pneumonectomy: current indications, complications, and results. J Thorac Cardiovasc Surg 2001; 121:484-90. [PMID: 11241083 DOI: 10.1067/mtc.2001.112471] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Completion pneumonectomy is reported to be associated with high morbidity and mortality, especially when done in patients with benign disease. We review our 9 years of experience with this operation to evaluate the postoperative outcome and long-term results of various indications. METHODS Between January 1990 and December 1998, 66 consecutive patients underwent completion pneumonectomy (6.8% of all pneumonectomies), and their cases were retrospectively reviewed. The indication was benign disease in 17 patients and malignant disease in 49 patients. In patients with malignant indications there were 14 local recurrences, 4 second primary tumors, 5 metastatic diseases, and 26 indications because of incomplete initial resection. RESULTS There were no intraoperative deaths, and the postoperative mortality rate was 7.6%. Complications were encountered in 32 (53%) patients, without any significant difference between benign indication (71%) and malignant indication (47%; P =.0923). Bronchopleural fistula was encountered in 5 (7.6%) patients, and empyema was encountered in 7 (11%) patients. The actuarial 5-year survival was 57% for all patients, 65% for those with benign indications, and 54% for those with malignant indications (60% for local recurrence, 50% for second primary tumor, and 56% for incomplete resection), without any difference between benign and malignant indications (P =.9478). CONCLUSIONS Completion pneumonectomy can be performed with acceptable mortality and morbidity, even in patients with benign disease. Patients with preoperative infection can be managed with bronchial stump covering and adequate postoperative drainage. Although complications are common, they can successfully be managed with a proper understanding of them.
Collapse
Affiliation(s)
- T Fujimoto
- Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen-Heidhausen, Germany.
| | | | | | | | | | | | | | | | | | | |
Collapse
|